Actualités Brookfield Wealth Solutions Ltd - BNT | Actions New York Stock Exchange | ADVFN

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Brookfield Wealth Solutions Ltd (BNT)
Brookfield Wealth Solutions Ltd (BNT) Actualités

Brookfield Wealth Solutions Ltd (BNT)

59,56

-0,94

( -1,55% )

Mis à jour : 16:54:43

Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Bentley Pharmaceuticals Inc - Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A...

Bentley Pharmaceuticals Inc - Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 8-K CURRENT REPORT PURSUANT TO SECTION...

Bentley Board Approves Spin-off of Drug Delivery Business

The board of directors of Bentley Pharmaceuticals, Inc. (NYSE: BNT) today approved the spin-off of its drug delivery business...

Bentley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Bentley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Bentley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Bentley Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)

Securities and Exchange Commission Washington, D. C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 ) Bentley...

Bentley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Bentley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Bentley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Bentley Pharmaceuticals Inc - Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ...

Bentley Pharmaceuticals Inc - Current report filing (8-K)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Bentley Pharmaceuticals Announces First Quarter Financial Results

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today reported financial results for the first...

Bentley Pharmaceuticals Inc - Amended Annual Report (10-K/A)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment...

Bentley Pharmaceuticals to Release First-Quarter 2008 Financial Results on May 8, 2008

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today announced that management will host a...

1
2
Suivant

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Brookfield Wealth Soluti...

Societe Generale Effekten

BNP Paribas Issuance

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales